Results 121 to 130 of about 2,224,846 (160)

AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma. [PDF]

Mil Med Res
Cho WC, Li KP, Wong CF, Fung KY, Chow JCH, Cheung KM, Chan JCH, Lau EYT.   +7 more
europepmc   +1 more source

Prognostic significance of calcium-related genes in lung adenocarcinoma and the role of <i>TNNC1</i> in macrophage polarization and erlotinib resistance. [PDF]

Front Immunol
Feng J, Chen Z, Wang G, Yao Y, Min X, Luo J, Xie K.   +6 more
europepmc   +1 more source

Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells. [PDF]

RSC Adv, 2021
Fisher L.
europepmc   +1 more source

Mesenchymal stem cells promote erlotinib resistance in non-small cell lung cancer through the HGF-AKT/ERK1/2-OPN pathway. [PDF]

Am J Transl Res
Yang Y, He J, Long F, Liu Y, Lin L, Wei H.   +5 more
europepmc   +1 more source

The long non-coding RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by inducing epithelial-mesenchymal transition via the miR-181a-5p/ROCK2 axis. [PDF]

Am J Cancer Res
Zhou W, Li X, Zhang B, Peng H, Quan C, Xiao X, Luo M, Huang Y, Xu D, Huang K, Jin Q, Lu S.   +11 more
europepmc   +1 more source

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling. [PDF]

Onco Targets Ther, 2020
Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J.   +7 more
europepmc   +1 more source

BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment. [PDF]

Cancer Biol Ther, 2020
Wang F, Zhang L, Sai B, Wang L, Zhang X, Zheng L, Tang J, Li G, Xiang J.   +8 more
europepmc   +1 more source

Human bone marrow mesenchymal stem cell-driven LncRNA PTCSC3 upregulation within lung adenocarcinoma cells reduces erlotinib resistance by mitigating Wnt/β-Catenin pathway. [PDF]

Am J Cancer Res
Chen B, Zhang B, García Cenador MB.
europepmc   +1 more source

Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells. [PDF]

Sci Rep, 2020
Lin Y, Higashisaka K, Shintani T, Maki A, Hanamuro S, Haga Y, Maeda S, Tsujino H, Nagano K, Fujio Y, Tsutsumi Y.   +10 more
europepmc   +1 more source

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC. [PDF]

Cell Prolif, 2019
Wang J, Zhou P, Wang X, Yu Y, Zhu G, Zheng L, Xu Z, Li F, You Q, Yang Q, Zhuo W, Sun J, Chen Z.   +12 more
europepmc   +1 more source